Ukraine's antitrust authority fines Sanofi-Aventis's local branch
This article was originally published in Scrip
Executive Summary
Ukraine's antimonopoly committee has imposed a Hr200,000 ($25,000) fine on Sanofi-Aventis's local subsidiary for spreading false information about generic enoxaparin (Sanofi-Aventis's low-molecular weight heparin Lovenox) produced by the local manufacturer Farmak and marketed as Flenox.